Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
GENTEX CORP
Report date March 01, 2018 · Filed March 02, 2018
Section 16 reporting ended · disclosed 2018-03-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,120 |
Ending reported balance
After 2018-03-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-03-01 · Exercise / conversion · Acquired 1,060 · Balance 22,180 Row 2 · 2018-03-01 · Sale · Disposed 1,060 · Balance 21,120 F1: This transaction was executed in multiple trades at prices ranging from $22.50 USD to $22.515 USD; the price reported above reflects the weighted average sale price. |
| Employee Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.70 · Expires 2023-02-22 | Direct | 0 |
Reported balance
After 2018-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-03-01 · Exercise / conversion · Disposed 1,060 · Balance 0 F2: 7-Year Grant; 20% Vesting every year for 5 years w/2 open years beginning on 22-Feb-2016 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $22.50 USD to $22.515 USD; the price reported above reflects the weighted average sale price.
F2: 7-Year Grant; 20% Vesting every year for 5 years w/2 open years beginning on 22-Feb-2016
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2018 Filed Mar 2, 2018 12:25 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 1,060 | $14.70 Strike: $14.70 | $15,582.00 |
DisclosureSEC source: 0001562180-18-001344 · primarydocument.xml · derivative · entry 3 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,060 shares Expires 2023-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 7-Year Grant; 20% Vesting every year for 5 years w/2 open years beginning on 22-Feb-2016 Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 12:25 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 1,060 | $22.51 | $23,860.49 |
DisclosureSEC source: 0001562180-18-001344 · primarydocument.xml · nonDerivative · entry 2 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,120 F1 · price: This transaction was executed in multiple trades at prices ranging from $22.50 USD to $22.515 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 12:25 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 1,060 | $14.70 | $15,582.00 |
DisclosureSEC source: 0001562180-18-001344 · primarydocument.xml · nonDerivative · entry 1 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 18:52 UTC | GENTEX CORP GNTX · Entity 3954 | GrantEmployee Stock Option (Right to buy) · Derivative | 6,500 | $22.94 Strike: $22.94 | $149,110.00 |
DisclosureSEC source: 0001562180-18-001070 · primarydocument.xml · derivative · entry 2 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 6,500 shares Expires 2028-02-15 F3 · price: Options granted under the Gentex Corporation Employee Stock Option Plan, which is a Rule 16B-3 Plan. F4 · derivative.exercise_date: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 18:52 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-18-001070 · primarydocument.xml · nonDerivative · entry 1 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,120 F1 · shares: These shares vest 100% four years from grant award date. F2 · price: Shares granted under the Gentex Corporation Restricted Stock Plan, which is a Rule 16B-3 Plan. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:44 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionStock Option (Right to buy) · Derivative | 2,246 | $10.12 Strike: $10.12 | $22,718.29 |
DisclosureSEC source: 0001562180-17-001540 · primarydocument.xml · derivative · entry 12 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,246 shares Expires 2018-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:44 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 1,060 | $14.70 Strike: $14.70 | $15,582.00 |
DisclosureSEC source: 0001562180-17-001540 · primarydocument.xml · derivative · entry 11 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,240 Underlying: Common Stock · 1,060 shares Expires 2023-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:44 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 4,710 | $15.41 Strike: $15.41 | $72,581.10 |
DisclosureSEC source: 0001562180-17-001540 · primarydocument.xml · derivative · entry 10 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,356 Underlying: Common Stock · 4,710 shares Expires 2019-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:44 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 1,980 | $18.30 Strike: $18.30 | $36,234.00 |
DisclosureSEC source: 0001562180-17-001540 · primarydocument.xml · derivative · entry 9 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,970 Underlying: Common Stock · 1,980 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:44 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 4,710 | $20.31 | $95,655.86 |
DisclosureSEC source: 0001562180-17-001540 · primarydocument.xml · nonDerivative · entry 8 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,120 Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:44 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 2,246 | $20.31 | $45,614.24 |
DisclosureSEC source: 0001562180-17-001540 · primarydocument.xml · nonDerivative · entry 7 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,830 Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:44 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 1,060 | $20.31 | $21,527.65 |
DisclosureSEC source: 0001562180-17-001540 · primarydocument.xml · nonDerivative · entry 6 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,076 Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:44 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 1,980 | $20.31 | $40,212.02 |
DisclosureSEC source: 0001562180-17-001540 · primarydocument.xml · nonDerivative · entry 5 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,136 Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:44 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 1,060 | $14.70 | $15,582.00 |
DisclosureSEC source: 0001562180-17-001540 · primarydocument.xml · nonDerivative · entry 4 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:44 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 4,710 | $15.41 | $72,581.10 |
DisclosureSEC source: 0001562180-17-001540 · primarydocument.xml · nonDerivative · entry 3 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:44 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 2,246 | $10.12 | $22,718.29 |
DisclosureSEC source: 0001562180-17-001540 · primarydocument.xml · nonDerivative · entry 2 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 12:44 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 1,980 | $18.30 | $36,234.00 |
DisclosureSEC source: 0001562180-17-001540 · primarydocument.xml · nonDerivative · entry 1 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 17:46 UTC | GENTEX CORP GNTX · Entity 3954 | GrantEmployee Stock Option (Right to buy) · Derivative | 5,680 | $20.52 Strike: $20.52 | $116,553.60 |
DisclosureSEC source: 0001562180-17-000816 · primarydocument.xml · derivative · entry 2 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,680 Underlying: Common Stock · 5,680 shares Expires 2024-02-16 F3 · price: Options granted under the Gentex Corporation Employee Stock Option Plan, which is a Rule 16B-3 Plan. F4 · derivative.exercise_date: These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 17:46 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-000816 · primarydocument.xml · nonDerivative · entry 1 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,120 F1 · shares: Shares vest 100% five years from grant award date. F2 · price: Shares granted under the Gentex Corporation Restricted Stock Plan, which is a Rule 16B-3 Plan. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 19:10 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 2,244 | $10.12 Strike: $10.12 | $22,698.06 |
DisclosureSEC source: 0001562180-16-003590 · primarydocument.xml · derivative · entry 3 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,246 Underlying: Common Stock · 2,244 shares Expires 2018-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 19:10 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 2,244 | $18.00 | $40,396.04 |
DisclosureSEC source: 0001562180-16-003590 · primarydocument.xml · nonDerivative · entry 2 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,370 Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 19:10 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 2,244 | $10.12 | $22,698.06 |
DisclosureSEC source: 0001562180-16-003590 · primarydocument.xml · nonDerivative · entry 1 Matthews Joseph E IV · CIK 0001615149 · Vice President Purchasing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.